Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Perilipins: a diversity of intracellular lipid droplet proteins

Itabe H., Yamaguchi T., Nimura S., Sasabe N.

Narrative Review on Face & Skin, published in Lipids Health Dis (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Lipids Health Dis (2017)
Reported sample size
—
Source database
Europe PMC
PMID
28454542
PMCID
PMC5410086
DOI
10.1186/s12944-017-0473-y
Citations
256

Abstract (original English)

Intracellular lipid droplets (LDs) are found in a wide variety of cell types and have been recognized as organelles with unique spherical structures. Although LDs are not stable lipid-depots, they are active sites of neutral lipid metabolism, and comprise neutral lipid or cholesterol cores surrounded by phospholipid monolayers containing specialized proteins. However, sizes and protein compositions vary between cell and tissue types. Proteins of the perilipin family have been associated with surfaces of LDs and all carry a conserved 11-mer repeat motif. Accumulating evidence indicates that all perilipins are involved in LD formation and that all play roles in LD function under differing conditions. In this brief review, we summarize current knowledge of the roles of perilipins and lipid metabolizing enzymes in a variety of mammalian cell types.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Endoplasmic ReticulumMitochondriaAdipocytesAnimalsHumansCholesterolHydroxysteroid DehydrogenasesTriglyceridesSignal TransductionGene Expression Regulation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research